Author
Koji Fujita
0 works0 citations
Recent research
- Health & MedicineOpen access
Abstract Background Bosutinib, a selective Src/c-Abl inhibitor approved for the treatment of chronic myelogenous leukemia (CML), was identified as a molecularly targeted therapeutic candidate for amyotrophic lateral sclerosis (ALS) through induced pluripotent stem cell-based drug...